Home
Scholarly Works
DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS...
Conference

DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS LOW FRACTURE INCIDENCE IN WOMEN >= 75 YEARS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO)

Authors

Papapoulos S; Mcclung MR; Franchimont N; Adachi JD; Bone HG; Benhamou C-L; Farrerons J; Gallagher JC; Halse J; Lippuner K

Volume

24

Pagination

pp. S45-S46

Publisher

SPRINGER LONDON LTD

Publication Date

April 1, 2013

Name of conference

European Congress on Osteoporosis and Osteoarthritis (ESCEO-IOF)

Conference place

Rome, ITALY

Conference start date

April 17, 2013

Conference end date

April 20, 2013

Conference proceedings

OSTEOPOROSIS INTERNATIONAL

ISSN

0937-941X

Labels

Contact the Experts team